FETAL HORMONAL ADAPTATION TO INTRAUTERINE STRESS
胎儿激素对宫内压力的适应
基本信息
- 批准号:3319105
- 负责人:
- 金额:$ 16.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-09-01 至 1989-08-31
- 项目状态:已结题
- 来源:
- 关键词:adrenocorticotropic hormone arginine vasopressin blood glucose cardiovascular function catecholamines centrifugation cortisol embryo /fetus death embryo /fetus hypoxia environmental adaptation gastrointestinal motility /pressure glucagon hormone regulation /control mechanism metabolism pancreatic islet function pregnancy circulation pregnancy disorder pregnancy loss prenatal growth disorder prenatal stress prolactin radioimmunoassay radionuclide diagnosis radiotracer respiratory gas analyzer scintillation spectrometry
项目摘要
Abnormalities of the intrauterine environment may be acute or chronic in
nature and are associated with increased perinatal morbidity and
mortality. For example, fetuses with growth retardation are less able to
tolerate decreases in uterine blood flow (UBF) as evidenced by abnormal
Apgar Scores, the occurrence of meconium-stained amniotic fluid, and
increased perinatal mortality. Understanding the fetal responses to these
adverse intrauterine events is predicated upon understanding the complex
integrated physiologic responses that might occur. Thus, the broad
objective of this project is to delineate and integrate neurohumoral,
cardiovascular, and metabolic events associated with fetal "distress." The
specific aims are to determine: whether arginine vasopressin (AVP) is
important in the release of other neurohumoral agents elevated in response
to fetal "distress", e.g., ACTH and cortisol, and delineate their
interaction; if an interaction exists between fetal AVP release, glucagon
secretion, and glucose homeostasis; if interactions exist between
catecholamines (C) and AVP during fetal "distress"; and finally, what is
the pattern of prolactin (PRL) secretion during fetal "stress" and its
interaction with AVP and ACTH. To accomplish these aims, studies have been
designed utilizing chronically-instrumented pregnant ewes and fetal sheep
studied remote from surgery and in the last third of pregnancy, 110 days to
term (term=144+5 days). The patterns of hormonal secretion and interaction
will be determined from serial observations obtained before, during, and
after an experimental intervention, measuring hormones by radioimmunoassay
(AVP, C, ACTH, PRL, and cortisol), while continuously monitoring UBF, heart
rate, blood pressure, amniotic fluid pressure, O2 content, and arterial
PO2, PCO2, and pH in the mother and fetus. In selected studies blood
glucose and lactate will be determined and alterations in fetal regional
blood flows evaluated using radiolabelled microspheres. The role of AVP in
the pathogenesis of fetal meconium release will be examined by monitoring
gastrointestinal intraluminal pressure, i.e., peristalsis. Degrees of
fetal "distress" will be obtained by acutely decreasing UBF with infusions
of C and/or arterial vascular occluders. Finally, the actions of AVP
(neurohumoral, cardiovascular, or metabolic) will be blocked using passive
immunization with AVP-antiserum. From the results of these studies a
better understanding of fetal adaptation to intrauterine "stress" and
hormonal interaction will be obtained.
宫内环境异常可能是急性的,也可能是慢性的。
性质并与围产期发病率增加有关
死亡。 例如,生长迟缓的胎儿的能力较差。
耐受子宫血流量(UBF)减少,如异常所证明
阿普加评分、羊水胎粪染色的发生率,以及
围产期死亡率增加。 了解胎儿对这些的反应
宫内不良事件的发生取决于对复杂情况的了解
可能发生的综合生理反应。 因此,广泛的
该项目的目标是描述和整合神经体液,
与胎儿“窘迫”相关的心血管和代谢事件。 这
具体目标是确定: 精氨酸加压素 (AVP) 是否
对于响应升高的其他神经体液药物的释放很重要
胎儿的“痛苦”,例如促肾上腺皮质激素和皮质醇,并描绘出它们的
相互作用;如果胎儿 AVP 释放与胰高血糖素之间存在相互作用
分泌和葡萄糖稳态;如果之间存在相互作用
胎儿“窘迫”期间的儿茶酚胺 (C) 和 AVP;最后,什么是
胎儿“应激”期间催乳素(PRL)的分泌模式及其
与 AVP 和 ACTH 相互作用。 为了实现这些目标,研究人员进行了
利用长期接受检测的怀孕母羊和胎羊设计
研究远离手术,在怀孕的最后三分之一,即 110 天
期限(期限=144+5天)。 荷尔蒙分泌和相互作用的模式
将根据之前、期间和期间获得的连续观察来确定
实验干预后,通过放射免疫测定法测量激素
(AVP、C、ACTH、PRL 和皮质醇),同时持续监测 UBF、心脏
心率、血压、羊水压、O2 含量和动脉
母亲和胎儿的 PO2、PCO2 和 pH 值。 在选定的研究中,血液
将测定葡萄糖和乳酸以及胎儿区域的变化
使用放射性标记的微球评估血流。 AVP的作用
通过监测来检查胎儿胎便释放的发病机制
胃肠道腔内压力,即蠕动。 度数
胎儿“窘迫”将通过输注急剧减少UBF来实现
C 和/或动脉血管封堵器。 最后,AVP的动作
(神经体液、心血管或代谢)将被被动阻断
用 AVP 抗血清进行免疫。 从这些研究的结果来看
更好地了解胎儿对宫内“压力”的适应
将获得荷尔蒙相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES RICHARD ROSENFELD其他文献
CHARLES RICHARD ROSENFELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES RICHARD ROSENFELD', 18)}}的其他基金
MULTICENTER NETWORK OF NEONATAL INTENSIVE CARE UNITS
新生儿重症监护病房的多中心网络
- 批准号:
6895903 - 财政年份:2001
- 资助金额:
$ 16.76万 - 项目类别:
Multicenter Network of Neonatal Intensive Care Units
新生儿重症监护室多中心网络
- 批准号:
6615684 - 财政年份:2001
- 资助金额:
$ 16.76万 - 项目类别:
MULTICENTER NETWORK OF NEONATAL INTENSIVE CARE UNITS
新生儿重症监护病房的多中心网络
- 批准号:
6743200 - 财政年份:2001
- 资助金额:
$ 16.76万 - 项目类别:
FETAL HORMONAL ADAPTATION TO INTRAUTERINE STRESS
胎儿激素对宫内压力的适应
- 批准号:
3319108 - 财政年份:1986
- 资助金额:
$ 16.76万 - 项目类别:
FETAL HORMONAL ADAPTATION TO INTRAUTERINE STRESS
胎儿激素对宫内压力的适应
- 批准号:
3319107 - 财政年份:1986
- 资助金额:
$ 16.76万 - 项目类别:
相似海外基金
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10641669 - 财政年份:2022
- 资助金额:
$ 16.76万 - 项目类别:
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10356395 - 财政年份:2022
- 资助金额:
$ 16.76万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10671052 - 财政年份:2021
- 资助金额:
$ 16.76万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10283131 - 财政年份:2021
- 资助金额:
$ 16.76万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10470346 - 财政年份:2021
- 资助金额:
$ 16.76万 - 项目类别:
Physiological role of arginine vasopressin released from RGCs on circadian rhythm and psychiatry function
RGC 释放的精氨酸加压素对昼夜节律和精神功能的生理作用
- 批准号:
19K06939 - 财政年份:2019
- 资助金额:
$ 16.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of mechanisms of arginine vasopressin receptor 1A in peripheral neuropathic pain
精氨酸加压素受体 1A 在周围神经病理性疼痛中的作用机制的鉴定
- 批准号:
18K16609 - 财政年份:2018
- 资助金额:
$ 16.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Functional mapping of arginine vasopressin receptor 1A circuits that promote anorexic behavior
促进厌食行为的精氨酸加压素受体 1A 电路的功能图谱
- 批准号:
10321547 - 财政年份:2018
- 资助金额:
$ 16.76万 - 项目类别:
Usefulness of arginine vasopressin levels on admission in risk stratification of acute decompensated heart failure with preserved left ventricular ejection fraction
入院时精氨酸加压素水平在左心室射血分数保留的急性失代偿性心力衰竭风险分层中的作用
- 批准号:
16K09448 - 财政年份:2016
- 资助金额:
$ 16.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Variation in the arginine vasopressin 1a receptor (AVPR1a) gene, the social environment, general health and wellbeing
精氨酸加压素 1a 受体 (AVPR1a) 基因的变异、社会环境、总体健康和福祉
- 批准号:
DP130100612 - 财政年份:2013
- 资助金额:
$ 16.76万 - 项目类别:
Discovery Projects














{{item.name}}会员




